30.09.2022 MEDIQON Group AG  DE0006618309

EQS-News: MEDIQON Group AG: Interim Report 2022 – Positive development of the group in the first half of 2022


 

EQS-News: MEDIQON Group AG / Key word(s): Half Year Report
MEDIQON Group AG: Interim Report 2022 – Positive development of the group in the first half of 2022

30.09.2022 / 12:25 CET/CEST
The issuer is solely responsible for the content of this announcement.


MEDIQON Group AG: Interim Report 2022 – Positive development of the group in the first half of 2022

Today, MEDIQON Group AG published its Interim Report 2022.
  • In the first half of 2022, 3 additional operating companies became part of the group. As of June 30, 2022, a total of 22 operating companies belong to the group, two of which are minority holdings in non-public entities.
     
  • Total group revenue for the first half year 2022 amounts to EUR 24.7 MM, thereof EUR 19.7 MM attributable to companies in which the group holds a majority stake.
     
  • Adjusted EBITDA of all operating companies belonging to the group for the first half year 2022 amounts to EUR 6.9 MM – thereof EUR 6.5 MM attributable to companies in which the group holds a majority stake.
     
  • The Base Value amounts to EUR 6.39 per share (31.12.2021: EUR 4.69 per share).
     
  • Adjusted Earnings amount to EUR 0.15 per share (31.12.2021: EUR 0.38 per share).
     
CFO Marlene Carl:

“The overall positive development of all key figures reflects the stable earning power of the operating group companies. We are delighted that the growth of the group continued again in the first half of the year, and we would like to thank all the teams at our subsidiaries for the good results!”

CEO Jan-Hendrik Mohr adds:

“The operating companies performed well in the turbulent macroeconomic environment in the first half of 2022. The current capital market volatility is reflected in our securities portfolio quite pronounced at the moment. We have used the upheavals to selectively build up stock positions and see considerable opportunities for MEDIQON Group AG in the coming weeks and months.”

In addition to the financial statement for MEDIQON Group AG as the parent, the company also published the first-time and voluntarily prepared consolidated interim accounts. The financial statements are unaudited.

The Interim Report 2022 can be downloaded via the website of the company: Annual and Interim Reports - MEDIQON group AG (mediqon-group.de).
 


30.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MEDIQON Group AG
Herzog-Adolph-Strasse 2
61462 Königstein im Taunus
Germany
Phone: +49 (0) 6174-9687040
Fax: +49 (0) 6174-9687043
E-mail: [email protected]
Internet: www.mediqon-group.de
ISIN: DE0006618309, DE000A254TL0
WKN: 661830, A254TL
Listed: Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Stuttgart
EQS News ID: 1453953

 
End of News EQS News Service

1453953  30.09.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1453953&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 3,21 2,64 0,10 1,08 28,66 42,07 0,00
EBITDA1,2 0,72 8,99 -0,44 -0,61 6,21 10,50 0,00
EBITDA-Marge3 22,43 340,53 -440,00 -56,48 21,67 24,96
EBIT1,4 0,51 8,65 -5,51 -2,56 0,94 2,51 0,00
EBIT-Marge5 15,89 327,65 -5.510,00 -237,04 3,28 5,97 0,00
Jahresüberschuss1 0,54 7,51 -5,01 -2,27 -2,27 -6,60 0,00
Netto-Marge6 16,82 284,47 -5.010,00 -210,19 -7,92 -15,69 0,00
Cashflow1,7 0,75 7,85 -5,00 -1,13 2,87 5,69 0,00
Ergebnis je Aktie8 0,24 3,04 -1,50 -0,18 0,38 0,05 0,23
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Chapters Group
WKN Kurs in € Einschätzung Börsenwert in Mio. €
661830 21,000 Kaufen 346,48
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
42,00 17,40 2,41 66,67
KBV KCV KUV EV/EBITDA
3,55 60,86 8,24 36,41
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 09.07.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
29.09.2023 24.05.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
3,95% 26,63% 14,75% 46,85%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MEDIQON Group AG  ISIN: DE0006618309 können Sie bei EQS abrufen


Beteiligungen , 661830 , CHG , XETR:CHG